JUN 11, 2022 3:29 PM PDT

Inhaled Aerosol Vaccines More Effective than Nasal Sprays

WRITTEN BY: Annie Lennon

Inhaled aerosol vaccines provide more protection than nasal sprays, and evoke a stronger immune response. The corresponding study was published in Frontiers in Immunology

"This study for the first time provides strong preclinical evidence to support the development of inhaled aerosol delivery over nasal spray for human vaccination against respiratory infections including TB, COVID-19 and influenza," says Zhou Xing, co-investigator of the study and a professor at the McMaster Immunology Research Centre and Department of Medicine.

Over 6.3 million people died worldwide while having COVID-19 during the COVID-19 pandemic. Other respiratory infections, such as tuberculosis, remain significant causes of severe disease and death globally. Developing vaccines that target these conditions is crucial to save lives and prevent their spread.

In particular, researchers are developing vaccine delivery methods that can deliver drugs directly to the mucous lining of the respiratory tract. There are currently two main methods: nasal sprays, which primarily reach the nose and throat, and inhaled aerosols, which bypass the nasal canal and deliver vaccines deep inside the airway. 

Previous research has demonstrated that while nasal mist flu vaccines are highly effective in children, they are less so for adults. This has meant that injectable flu vaccines have remained the most popular choice for seasonal flu vaccines. 

To see whether inhaled aerosol vaccines could be effective against lower respiratory tract infections, researchers investigated the effects of a tuberculosis vaccine delivered either by nasal spray or inhaled aerosols in a mouse model. In doing so, they found that inhaled aerosols increased biodistribution in the lungs, and improved vaccine-mediated immunogenicity and protection. 

"The immune response you generate when you deliver the vaccine deep into the lung is much stronger than when you only deposit that material in the nose and throat because of the anatomy and nature of the tissue, and the immune cells that are available to respond are very different," said Matthew Miller, a co-author of the study who holds the Canada Research Chair in Viral Pandemics at McMaster University.

The researchers are now investigating this vaccine delivery method in a Phase 1 clinical trial involving adults who had previously received two or three doses of the injected COVID-mRNA vaccine. 

 

Sources: Science Daily, Frontiers in Immunology

 

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 20, 2022
Microbiology
Halting the Assembly of Dangerous Paramyxoviruses Like Nipah
JUL 20, 2022
Halting the Assembly of Dangerous Paramyxoviruses Like Nipah
The paramyxovirus includes serious pathogens that can cause pandemics, including ones that lead primarily to mild. Illne ...
JUL 23, 2022
Drug Discovery & Development
No Evidence for Depression and Serotonin Activity Link
JUL 23, 2022
No Evidence for Depression and Serotonin Activity Link
A new review study found that there is no clear evidence that serotonin levels or serotonin activity are responsible for ...
AUG 16, 2022
Cannabis Sciences
Do Cannabis Users Have More Sinonasal Symptoms?
AUG 16, 2022
Do Cannabis Users Have More Sinonasal Symptoms?
A study examined the association between cannabis use and sinonasal symptoms and found an association between higher fre ...
AUG 17, 2022
Drug Discovery & Development
A new software platform to help with drug discovery efficiency
AUG 17, 2022
A new software platform to help with drug discovery efficiency
The process of drug discovery and development is expensive. A recent report from the Journal of the American M ...
OCT 03, 2022
Technology
Scientists Develop "RoboCap" Capsule to Deliver Drugs to Digestive Tract
OCT 03, 2022
Scientists Develop "RoboCap" Capsule to Deliver Drugs to Digestive Tract
In a recent study published in Science Robotics, a team of researchers led by the Massachusetts Institute of Technology ...
OCT 04, 2022
Cancer
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
OCT 04, 2022
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
In August, President Biden announced his intention to appoint Dr. Monica M. Bertagnolli as the newest director of the Na ...
Loading Comments...